 FDA Information - November 20, 2008
|
The FDA cleared a device, known as the Vagus Nerve Stimulation Therapy System (VNS), for long-term use for patients with depression. The device is implanted in the chest and sends impulses to the brain through a nerve in the neck |
|
The Food and Drug Administration orders a halt to the sales of the drug Palladone, citing potentially fatal reactions when coupled with alcohol. The drug was approved just last September. The FDA says data from a recent study shows taking the drug with alcohol can harm the capsule's slow release function, rapidly streaming the narcotic through the bloodstream, possible causing an overdose |
|
A U.S. advisory panel has unanimously said that three GlaxoSmithKline Plc, and Novartis AG, asthma drugs are safe enough to stay on the market despite concerns that they raise the risk of severe asthma attacks in rare cases. Panel members said the drugs' benefits of controlling asthma symptoms and improving lung function outweighed the small possibility of a life-threatening asthma attack |
|
The Food and Drug Administration of Maharashtra, in India, has prohibited sale of the well-known Australian energy drink "Red Bull," following a complaint about an ingredient. FDA Commissioner, M Rameshkumar, has confirmed to the media that Red Bull was not being sold in Mumbai, and the FDA was seeking certification from the manufacturers to prove that taurine, an amino acid used in the drink, was synthetically manufactured |
|
Green tea probably does not help prevent breast, prostate or any other type of cancer, the U.S. Food and Drug Administration said on Thursday. THE F.D.A. went on to say that studies supporting the assertions about the medical power of green tea are weak |
|